Generation of an hiPSC-Derived Co-Culture System to Assess the Effects of Neuroinflammation on Blood–Brain Barrier Integrity
The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
The blood–brain barrier (BBB) regulates the interaction between the highly vulnerable central nervous system (CNS) and the peripheral parts of the body. Disruption of the BBB has been associated with multiple neurological disorders, in which immune pathways in microglia are suggested to play a key role. Currently, many in vitro BBB model systems lack a physiologically relevant microglia component in order to address questions related to the mechanism of BBB integrity or the transport of molecules between the periphery and the CNS. To bridge this gap, we redefined a serum-free medium in order to allow for the successful co-culturing of human inducible pluripotent stem cell (hiPSC)-derived microglia and hiPSC-derived brain microvascular endothelial-like cells (BMECs) without influencing barrier properties as assessed by electrical resistance. We demonstrate that hiPSC-derived microglia exposed to lipopolysaccharide (LPS) weaken the barrier integrity, which is associated with the secretion of several cytokines relevant in neuroinflammation. Consequently, here we provide a simplistic humanised BBB model of neuroinflammation that can be further extended (e.g., by addition of other cell types in a more complex 3D architecture) and applied for mechanistic studies and therapeutic compound profiling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Lipopolysaccharides (LPS) is commonly used to induce an inflammatory response in microglia by activating the TLR4 pathway, initiating the innate immune response, resulting in the secretion of inflammatory cytokines and chemokines [43 -45].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Blood-Brain Barrier: From Physiology to Disease and Back
Sweeney, M. D., Zhao, Z., Montagne, A., Nelson, A. R., & Zlokovic, B. V. (2019) · Physiological Reviews · doi:10.1152/physrev.00050.2017 · Cited by 2,312
Microglia emerge as central players in brain disease
Salter, M. W., & Stevens, B. (2017) · Nature Medicine · doi:10.1038/nm.4397 · Cited by 1,767
Fantin, A., Vieira, J. M., Gestri, G., Denti, L., Schwarz, Q., Prykhozhij, S., Peri, F., Wilson, S. W., & Ruhrberg, C. (2010) · Blood · doi:10.1182/blood-2009-12-257832 · Cited by 1,153
Dual microglia effects on blood brain barrier permeability induced by systemic inflammation
Haruwaka, K., Ikegami, A., Tachibana, Y., Ohno, N., Konishi, H., Hashimoto, A., Matsumoto, M., Kato, D., Ono, R., Kiyama, H., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-13812-z · Cited by 923 · cited 1×
“In the context of an experimental in vivo model of systemic inflammation induced by LPS, it was proposed that microglia can be stimulated to migrate towards the cerebral vasculature and initially help to maintain the BBB before sustained inflammation impairs BBB function [38].”
BackgroundDerivation of blood-brain barrier endothelial cells from human pluripotent stem cells
Lippmann, E. S., Azarin, S. M., Kay, J. E., Nessler, R. A., Wilson, H. K., Al-Ahmad, A., Palecek, S. P., & Shusta, E. V. (2012) · Nature Biotechnology · doi:10.1038/nbt.2247 · Cited by 800 · cited 1×
“co-culturing of hiPSC-derived BMECs with pericytes, astrocytes and/or neurons significantly elevates the TEER [50,51].”
BackgroundNeuroinflammation as a common feature of neurodegenerative disorders
Guzman-Martinez, L., Maccioni, R. B., Andrade, V., Navarrete, L. P., Pastor, M. G., & Ramos-Escobar, N. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01008 · Cited by 702
Vatine, G. D., Barrile, R., Workman, M. J., Sances, S., Barriga, B. K., Rahnama, M., Barthakur, S., Kasendra, M., Lucchesi, C., Kerns, J., et al. (2019) · Cell stem cell · doi:10.1016/j.stem.2019.05.011 · Cited by 632 · cited 1×
“A recent transcriptomic meta-analysis has shown hiPSC-derived BMECs to express epithelial genes, as well as possess an inadequate expression of genes related to vascular lineage [46,48].”
BackgroundHaenseler, W., Sansom, S. N., Buchrieser, J., Newey, S. E., Moore, C. S., Nicholls, F. J., Chintawar, S., Schnell, C., Antel, J. P., Allen, N. D., et al. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.05.017 · Cited by 593
The neurovascular unit - concept review
Muoio, V., Persson, P. B., & Sendeski, M. M. (2014) · Acta Physiologica · doi:10.1111/apha.12250 · Cited by 564
McQuade, A., Kang, Y. J., Hasselmann, J., Jairaman, A., Sotelo, A., Coburn, M., Shabestari, S. K., Chadarevian, J. P., Fote, G., Tu, C. H., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19227-5 · Cited by 361 · cited 1×
“Although TGF-β1 is crucial for microglial homeostasis, it has been demonstrated that rhTGF-β1 supplementation is not important for mature hiPSC derived-microglial survival in vitro [36].”
BackgroundGenome-wide pleiotropy between Parkinson disease and autoimmune diseases
Witoelar, A., Jansen, I. E., Wang, Y., Desikan, R. S., Gibbs, J. R., Blauwendraat, C., Thompson, W. K., Hernandez, D. G., Djurovic, S., Schork, A. J., et al. (2017) · JAMA Neurology · doi:10.1001/jamaneurol.2017.0469 · Cited by 352
Shaftel, S. S., Carlson, T. J., Olschowka, J. A., Kyrkanides, S., Matousek, S. B., & O'Banion, M. K. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.1418-07.2007 · Cited by 243
Human pluripotent stem cell–derived brain pericyte–like cells induce blood-brain barrier properties
Stebbins, M. J., Gastfriend, B. D., Canfield, S. G., Lee, M.-S., Richards, D., Faubion, M. G., Li, W.-J., Daneman, R., Palecek, S. P., & Shusta, E. V. (2019) · Science Advances · doi:10.1126/sciadv.aau7375 · Cited by 195
Systemic factors as mediators of brain homeostasis, ageing and neurodegeneration
Pluvinage, J. V., & Wyss-Coray, T. (2020) · Nature Reviews Neuroscience · doi:10.1038/s41583-019-0255-9 · Cited by 191 · cited 1×
“The blood–brain barrier (BBB) is a key component of the NVU that, under homeostatic conditions, tightly regulates the exchange of molecules and cells between the peripheral blood and the brain parenchyma [4].”
BackgroundGeng, J., Wang, L., Zhang, L., Qin, C., Song, Y., Ma, Y., Chen, Y., Chen, S., Wang, Y., Zhang, Z., et al. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00129 · Cited by 123
Hall-Roberts, H., Agarwal, D., Obst, J., Smith, T. B., Monzón-Sandoval, J., Di Daniel, E., Webber, C., James, W. S., Mead, E., Davis, J. B., et al. (2020) · Alzheimer's Research & Therapy · doi:10.1186/s13195-020-00709-z · Cited by 62 · cited 1×
“This is most likely due to the variability in microglia re-plating numbers (day 10) and the transcriptional differences in the harvest age of the hiPSC-derived microglial cells [45].”
Background
Research works printed but not linked: 35
- Hawkins, 2005, The blood-brain barrier/neurovascular unit in health and disease, Pharmacol. Rev., 57, 173, 10.1124/pr.57.2.4 · DOI · Paper page
- Iadecola, 2017, The Neurovascular Unit Coming of Age: A Journey through Neurovascular Coupling in Health and Disease, Neuron, 96, 17, 10.1016/j.neuron.2017.07.030 · DOI · Paper page
- Abbott, 2010, Structure and function of the blood–brain barrier, Neurobiol. Dis., 37, 13, 10.1016/j.nbd.2009.07.030 · DOI · Paper page
- Zlokovic, 2008, The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders, Neuron, 57, 178, 10.1016/j.neuron.2008.01.003 · DOI · Paper page
- Heneka, 2015, Neuroinflammation in Alzheimer’s disease, Lancet Neurol., 14, 388, 10.1016/S1474-4422(15)70016-5 · DOI · Paper page
- Xiao, 2020, Blood-Brain Barrier: More Contributor to Disruption of Central Nervous System Homeostasis Than Victim in Neurological Disorders, Front. Neurosci., 14, 764, 10.3389/fnins.2020.00764 · DOI
- Beach, 1989, Patterns of gliosis in alzheimer’s disease and aging cerebrum, Glia, 2, 420, 10.1002/glia.440020605 · DOI · Paper page
- Fahn, 2018, The 200-year journey of Parkinson disease: Reflecting on the past and looking towards the future, Parkinsonism Relat. Disord., 46, S1, 10.1016/j.parkreldis.2017.07.020 · DOI
- Gogoleva, 2019, The Role of Microglia in the Homeostasis of the Central Nervous System and Neuroinflammation, Mol. Biol., 53, 696, 10.1134/S0026893319050054 · DOI
- Lambert, 2013, Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer’s disease, Nat. Genet., 45, 1452, 10.1038/ng.2802 · DOI · Paper page
- Kunkle, 2019, Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing, Nat. Genet., 51, 414, 10.1038/s41588-019-0358-2 · DOI · Paper page
- Gastfriend, 2018, Modeling the blood-brain barrier: Beyond the endothelial cells, Curr. Opin. Biomed. Eng., 5, 6, 10.1016/j.cobme.2017.11.002 · DOI · Paper page
- Speicher, 2019, Generating microglia from human pluripotent stem cells: Novel in vitro models for the study of neurodegeneration, Mol. Neurodegener., 14, 46, 10.1186/s13024-019-0347-z · DOI · Paper page
- Reich, 2021, Alzheimer’s Risk Gene TREM2 Determines Functional Properties of New Type of Human iPSC-Derived Microglia, Front. Immunol., 11, 3918, 10.3389/fimmu.2020.617860 · DOI · Paper page
- Chen, 2021, Efficient conversion of human induced pluripotent stem cells into microglia by defined transcription factors, Stem Cell Rep., 16, 1363, 10.1016/j.stemcr.2021.03.010 · DOI · Paper page
- Workman, 2020, Recent advances in human iPSC-derived models of the blood-brain barrier, Fluids Barriers CNS, 17, 30, 10.1186/s12987-020-00191-7 · DOI
- Prashanth, A., Donaghy, H., Stoner, S.P., Hudson, A.L., Wheeler, H.R., Diakos, C.I., Howell, V.M., Grau, G.E., and McKelvey, K.J. (2021). Are in vitro human blood–brain–tumor-barriers suitable replacements for in vivo models of brain permeability for novel therapeutics?. Cancers, 13. · DOI
- Park, 2019, Hypoxia-enhanced Blood-Brain Barrier Chip recapitulates human barrier function and shuttling of drugs and antibodies, Nat. Commun., 10, 2621, 10.1038/s41467-019-10588-0 · DOI · Paper page
- Morrison, 2015, StemBANCC: Governing Access to Material and Data in a Large Stem Cell Research Consortium, Stem Cell Rev., 11, 681, 10.1007/s12015-015-9599-3 · DOI · Paper page
- Gutbier, S., Wanke, F., Dahm, N., Rn, A., Zimmermann, S., Christensen, K., Köchl, F., Rautanen, A., Hatje, K., and Geering, B. (2020). Large-Scale Production of Human iPSC-Deriveümmelid Macrophages for Drug Screening. Int. J. Mol. Sci., 21. · DOI · Paper page
- Qin, 2007, Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration, Glia, 55, 453, 10.1002/glia.20467 · DOI · Paper page
- Simonneau, 2021, Investigating receptor-mediated antibody transcytosis using blood–brain barrier organoid arrays, Fluids Barriers CNS, 18, 43, 10.1186/s12987-021-00276-x · DOI
- Pardali, E., Sanchez-Duffhues, G., Gomez-Puerto, M.C., and ten Dijke, P. (2017). TGF-β-Induced Endothelial-Mesenchymal Transition in Fibrotic Diseases. Int. J. Mol. Sci., 18. · DOI · Paper page
- Ma, 2020, TGF-β-Induced Endothelial to Mesenchymal Transition in Disease and Tissue Engineering, Front. Cell Dev. Biol., 8, 260, 10.3389/fcell.2020.00260 · DOI · Paper page
- Ferrari, 2009, Transforming growth factor-beta 1 (TGF-beta1) induces angiogenesis through vascular endothelial growth factor (VEGF)-mediated apoptosis, J. Cell. Physiol., 219, 449, 10.1002/jcp.21706 · DOI · Paper page
- Nguyen, 2018, TGF-β1 alters esophageal epithelial barrier function by attenuation of claudin-7 in eosinophilic esophagitis, Mucosal Immunol., 11, 415, 10.1038/mi.2017.72 · DOI
- Evrard, 2016, Endothelial to mesenchymal transition is common in atherosclerotic lesions and is associated with plaque instability, Nat. Commun., 7, 11853, 10.1038/ncomms11853 · DOI · Paper page
- Spittau, 2020, The Role of TGFβ Signaling in Microglia Maturation and Activation, Trends Immunol., 41, 836, 10.1016/j.it.2020.07.003 · DOI · Paper page
- Yao, 2013, Monocyte chemoattractant protein-1 and the blood–brain barrier, Cell. Mol. Life Sci., 71, 683, 10.1007/s00018-013-1459-1 · DOI · Paper page
- Chai, 2015, Expression of Neuronal CXCL10 Induced by Rabies Virus Infection Initiates Infiltration of Inflammatory Cells, Production of Chemokines and Cytokines, and Enhancement of Blood-Brain Barrier Permeability, J. Virol., 89, 870, 10.1128/JVI.02154-14 · DOI
- Maysami, 2015, Prolonged diet-induced obesity in mice modifies the inflammatory response and leads to worse outcome after stroke, J. Neuroinflamm., 12, 140, 10.1186/s12974-015-0359-8 · DOI
- Ubogu, 2006, Determinants of CCL5-driven mononuclear cell migration across the blood–brain barrier. Implications for therapeutically modulating neuroinflammation, J. Neuroimmunol., 179, 132, 10.1016/j.jneuroim.2006.06.004 · DOI
- Lu, 2021, Pluripotent stem cell-derived epithelium misidentified as brain microvascular endothelium requires ETS factors to acquire vascular fate, Proc. Natl. Acad. Sci. USA, 118, e2016950118, 10.1073/pnas.2016950118 · DOI · Paper page
- Lippmann, 2020, Commentary on human pluripotent stem cell-based blood–brain barrier models, Fluids Barriers CNS, 17, 64, 10.1186/s12987-020-00222-3 · DOI
- Han, 2021, Roles of Macrophages in the Development and Treatment of Gut Inflammation, Front. Cell Dev. Biol., 9, 385, 10.3389/fcell.2021.625423 · DOI · Paper page
Cited by
Bull, D., Matte, J. C., Navarron, C. M., McIntyre, R., Whiting, P., Katan, M., Ducotterd, F., & Magno, L. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2023.166978 · Cited by 3
Self-citation
Metadata
- Authors
- Bull, D., Schweitzer, C., Bichsel, C., Britschgi, M., & Gutbier, S.
- Affiliations
- ARUK UCL Drug Discovery Institute, University College London, London WC1E 6BT, UK
- Roche Pharma Research and Early Development, Neuroscience and Rare Diseases Discovery and Translational Area, Roche Innovation Center Basel, 4070 Basel, Switzerland
- Roche Pharma Research and Early Development, Pharmaceutical Sciences and The Roche Institute for Translational Bioengineering, Roche Innovation Center Basel, 4070 Basel, Switzerland
- Roche Pharma Research and Early Development, Therapeutic Modalities, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., 4070 Basel, Switzerland
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2022-01-26
- Volume
- 11
- Issue
- 3
- Pages
- 419
- ISSN
- 2073-4409
- Cited by
- 14
- References
- 16
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.